Search results
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 2 hours agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 3 hours agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 hours agoImage source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q1 2024 Earnings Call May 06, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 7 hours agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 12 hours ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
Analyst Report: BioNTech SE
Morningstar Research via Yahoo Finance· 3 hours agoBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious ...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 12 hours agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 12 hours agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 12 hours agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 12 hours agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
